However, their clinical application is limited by an incomplete understanding of their immunogenicity. Now, researchers from Juntendo University developed a humanized mice model and elucidated the ...

LAWRENCEVILLE, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapy and evaluating an adaptation ...

Immunogenicity was assessed by hemagglutination-inhibition (HI) prevaccination and 28 days after each vaccination. Immunogenic non-inferiority QIV versus TIV for shared strains, and superiority ...

Imunon has reported new immunogenicity and safety data from its proof-of-concept Phase I trial’s ongoing analyses of the IMNN-101 DNA plasmid vaccine. The investigational vaccine, based on the ...

A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.

Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

Biocon’s ustekinumab biosimilar matched reference ustekinumab in efficacy and safety, while an adalimumab biosimilar proved ...

Presentation Details Title: Safety and Immunogenicity of PIV5-Vectored RSV Intranasal Vaccine (BLB201) in Healthy Adults and Children Date/Time: March 13, 2025 / 8:30 am to 8:45 am (GMT-3 ...

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.